ArticleJournal of clinical medicine2026

Dual Remission in Patients with Moderate-to-Severe Asthma and CRSwNP Treated with Dupilumab: A 24-Month Real-World Study.

Francesco Menzella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.